Health
Study reports highly potent anti-SARS-CoV-2 compounds – News-Medical.Net
A new study published on the preprint server bioRxiv in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary …
A new study published on the preprint server bioRxiv* in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary viral proteases. The authors urge rapid clinical and preclinical testing of their most potent compounds to meet the need for an effective antiviral therapeutics for the ongoing pandemic of COVID-19.
Introduction to the Viral Polyprotein Pr…
-
Noosa News19 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General21 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership